Despite advances,
cancer therapy selection
remains partly
hit or miss
Current diagnostic approaches, including genomic testing, cannot tell with accuracy whether a cancer therapy will be effective.
Get clear direction, faster. SAGE Oncotest™ evaluates treatment options against your live tumor cells to support more confident therapy selection in 7-10 days.
But There Is Hope -
SAGE Oncotest™
The SAGE Oncotest™ evaluates a curated list of FDA-approved drugs assessing their potential for treating your specific cancer.
Solid tumors such as ovarian cancer, pancreatic cancer, or brain cancer.
Solid tumors of unknown origin.
Getting Started With SAGE
Is Easy
STEP 1
Contact us prior to surgery or biopsy and we will coordinate with your physician.
STEP 2
A fresh tissue is taken during surgery or biopsy and shipped to SAGE.
STEP 3
Receive your SAGE Oncotest Report to significantly improve your understanding of which treatments may work most effectively for you.
Getting Started With SAGE
Is Easy
STEP 1
Contact us prior to surgery or biopsy and we will coordinate with your physician.
STEP 2
A fresh tissue is taken during surgery or biopsy and shipped to SAGE.
STEP 3
Receive your SAGE Oncotest Report to significantly improve your understanding of which treatments may work most effectively for you.
Frequently Asked
Questions
The SAGE Oncotest™ is intended for patients with solid tumors, especially aggressive, late-stage, metastatic, or recurrent tumors. It is helpful when treatment decisions involve chemotherapy, targeted therapy, or other systemic options.
You may be eligible if:
-
-
You are scheduled for surgery or a biopsy that can provide fresh, live tumor tissue, and
-
You will likely require chemo- or targeted therapy.
-
While the SAGE Oncotest™ can be used for most types of solid tumors, a physician’s order is required.
To quickly check whether you might qualify and benefit from the test, we recommend completing the eligibility questionnaire.
The SAGE Oncotest™ can test almost all cancers, including:
-
Ovarian and other gynecological cancers;
-
Triple negative, BRCA positive, metastatic, and other aggressive breast cancers;
-
Colorectal and other gastro-intestinal cancers;
-
Glioblastoma and other aggressive brain cancers.
-
Cancers of unknown origin (cancers of unknown primary, CUPs) and other rare cancers.
The SAGE Oncotest™ is not indicated for:
-
Very slow growing cancers of limited clinical relevance, e.g. low-grade breast or prostate cancers.
-
Early cancers where surgical excision is generally curative, e.g. small skin cancers, small (hazelnut size or smaller) breast cancers.
-
The SAGE Oncotest™ works with fresh, live tissue to see how your cancer responds to different medications. Thus, if you already had a previous biopsy or surgery, your sample was most likely placed into a preservative (e.g. in formalin) and subsequently paraffin embedded to cut and stain thin slices (histological slides), so that tissue will be dead and can no longer be used for the SAGE Oncotest™.
However, if you’re scheduled for a new procedure, you can ask your doctor to collect fresh tissue for the test to be sent to SageMedic. Just be aware that some cancer centers may claim ownership of excised tissue in their consent forms, so it’s important to communicate your intent ahead of time.